11-Jan-2013 - Bayer AG

Awards from the Bayer Science & Education Foundation

Bayer Early Excellence in Science Award 2012: EUR 30,000 for young research scientists

The winners of the Bayer Early Excellence in Science Award 2012 have been announced. The prizes, each worth EUR 10,000, have been awarded by an independent scientific committee of the Bayer Science & Education Foundation. The Bayer foundation presents for the fourth time the Bayer Early Excellence in Science Award to talented young scientists in the early stages of their academic careers.

“Research and science play a central role for the inventor company Bayer. I am delighted that these prizes give us the opportunity to support and motivate young scientists,” said Prof. Dr. Wolfgang Plischke, member of the Board of Management of Bayer AG responsible for Innovation, Technology and Sustainability, and member of the Board of Directors of the foundation. “Bayer’s innovation strategy has long focused on intensive exchange with colleges and universities. The targeted funding of young scientists is just one element of our program – cooperation and strategic partnerships are essential for successful industrial research,” continued Plischke.

This international prize was first presented in 2009. It is awarded annually in the three categories biology, chemistry and materials. The selection is made on the basis of the originality and quality of candidates’ research and the significance of this work for the respective award category.

Cancer Biology: New opportunities in tumor drug research

Dr. Christiane Opitz from the German Cancer Research Center (DKFZ) of the Helmholtz Association in Heidelberg receives the “Bayer Early Excellence in Science Award” 2012 in the category “Biology” for her outstanding contributions to the understanding of the relevance of the tryptophan metabolism for cancer biology. Together with her team she discovered the first endogenous ligand for the aryl hydrocarbon receptor (AHR) which is involved in promoting tumor growth and suppressing anti-tumor immune responses. The discovery of this new signalling pathway could enable the development of drugs which are expected to inhibit the malignant phenotype of cancer cells and restore anti-tumor immunity.

Selective Catalysis and Synthesis: New routes to highly functional small synthetic molecules

Dr. Nuno Maulide from the Max Planck Institut für Kohlenforschung in Mülheim receives the “Bayer Early Excellence in Science Award” 2012 in the category “Chemistry” for developing new routes to synthesize highly functional small ring molecules. These novel small molecules are excellent starting points for various active ingredients or natural products. By developing new synthetic methods beyond well-established chemical reactions the Maulide group has discovered unprecedented new phenomena and introduced novel concepts in the field of asymmetric catalysis while broadly contributing to a new set of tools to be used in all Life Sciences for stereoselective synthesis of small molecules.

Energy storage and transformation: Novel nanomaterials enabling the efficient use of renewable energies

Dr. Volker Presser from the INM – Leibniz-Institute for New Materials – in Saarbrücken receives the “Bayer Early Excellence in Science Award” 2012 in the category “Materials” for his research on novel nanomaterials that can be used in energy storage and transformation technologies. The work of his team focuses on the development of super- and pseudocapacitors using state-of-the-art methods like electrospinning and atomic layer deposition. Another research topic the newly developed and novel concept for electrochemical energy storage, the “flow capacitor”, in which specific features of redox flow batteries and supercapacitors have been synergistically combined. Volker Presser’s research contributes substantially to advancing the technologies urgently needed for efficient large-scale use of renewable energies and to energy storage through electrochemical processes.

Facts, background information, dossiers
  • Bayer
  • MPI für Kohlenforschung
  • Bayer Early Excelle…
  • awards
  • Deutsches Krebsfors…
  • Leibniz-Institut fü…
More about Bayer
  • News

    Bayer with continued strong performance

    The Bayer Group maintained its strong business performance across all three divisions in the third quarter. “Despite rising inflation and global supply chain problems, we were again able to boost sales and earnings,” said Werner Baumann, Chairman of the Board of Management, when presenting ... more

    Bayer: Very good start to the year – strong sales and earnings growth

    The Bayer Group had a very successful start to 2022. “We achieved outstanding sales and earnings growth, with particularly substantial gains for our agriculture business,” said Werner Baumann, Chairman of the Board of Management, on Tuesday as he presented the quarterly statement for the fi ... more

    Bayer to sell its Environmental Science Professional business to Cinven for 2.6 billion U.S. dollars

    Bayer and Cinven have entered into a definitive agreement regarding the sale of Bayer’s Environmental Science Professional business for a purchase price of 2.6 billion U.S. dollars (2.4 billion euros), Bayer announced on Thursday. “This divestment represents a very attractive purchase price ... more

  • Companies

    Bayer Bitterfeld GmbH


    Bayer Corporation

    Bayer Corporation, headquartered in Pittsburgh, is a subsidiary of Bayer AG, an international health care, nutrition and innovative materials group based in Leverkusen, Germany. In North America, Bayer had 2006 net sales of 7.8 billion euros and employed 17,200 at year end. Bayer’s three s ... more

    Bayer Technology Services México

    Bayer Technology Services stands for technological competence throughout the service life of processes or units. We support our customers from the development of innovative products and processes to engineering and construction of units, to operating control and optimization – with courage, ... more

More about Deutsches Krebsforschungszentrum
  • News

    Carcinogenic effect of inhaled formaldehyde sufficiently documented

    Formaldehyde is produced on a large scale around the world and is present in many consumer products. Small amounts of the substance are also formed during cell metabolism in man and animals. Formaldehyde is harmful; it irritates the mucous membranes and can trigger cancer in the nasopharynx ... more

More about MPI für Kohlenforschung
  • News

    One chemist to keep an eye on

    The American journal “Science news” awards ten young scientists each year as “scientists to watch”. Josep Cornellà, group leader at the Max-Planck-Institut für Kohlenforschung, is now one of them. For about one century the American magazine "Science News" has been reporting on current devel ... more

    More Sustainability with Mechanochemistry

    Flour, coffee or spices: Many people know the principle of a mill from the kitchen. But special mills are also used for research purposes in the laboratories of the Max-Planck-Institut für Kohlenforschung. The scientists are convinced that mechanochemistry can make the chemical industry mor ... more

    Nitrous oxide - anything but inert

    The emission of various greenhouse gases threatens the global environment, and scientists around the world are increasingly involved and committed to address this issue. While many research groups focus on carbon dioxide (C02) or methane (CH4) revalorization strategies, a team led by Dr. Jo ... more

More about Leibniz-Institut für Neue Materialien